In addition, the above-mentioned meta-analysis by Shi et al. revealed that high serum Gal-3 concentrations were associated with a high risk of adverse outcomes (all-cause death, composite events: all-cause death and HF hospitalization or CV death and HF hospitalization) in patients with HFpEF [100]. The gene discussed is LGALS3; the disease is hydrops fetalis.